Persistent URL of this record https://hdl.handle.net/1887/103489
In Collections
This item can be found in the following collections:
SAFETY AND EFFICACY OF ARA290, A NON-HEMATOPOIETIC ERYTHROPOIETIN DERIVED PEPTIDE, IN A 4 WEEKS PHASE II OPEN LABEL TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
- All authors
- Broek, M. van den; Allaart, C.F.; Brines, M.; Cerami, A.; Huizinga, T.W.
- Date
- 2013-06-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 72
- Pages
- 620 - 620